| Making choices in health: WHO guide to cost-effectiveness analysis World Health Organization | 1689* | 2003 |
| Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk CJL Murray, JA Lauer, RCW Hutubessy, L Niessen, N Tomijima, ... The Lancet 361 (9359), 717-725, 2003 | 794 | 2003 |
| Cost–effectiveness thresholds: pros and cons MY Bertram, JA Lauer, K De Joncheere, T Edejer, R Hutubessy, MP Kieny, ... Bulletin of the World Health Organization 94 (12), 925, 2016 | 696 | 2016 |
| Generalized cost-effectiveness analysis for national-level priority-setting in the health sector R Hutubessy, D Chisholm, TTT Edejer, WHO-CHOICE Cost effectiveness and resource allocation 1, 1-13, 2003 | 605 | 2003 |
| Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ... The Lancet 395 (10224), 575-590, 2020 | 592 | 2020 |
| Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries K Canfell, JJ Kim, M Brisson, A Keane, KT Simms, M Caruana, EA Burger, ... The Lancet 395 (10224), 591-603, 2020 | 438 | 2020 |
| Programme costs in the economic evaluation of health interventions B Johns, R Baltussen, R Hutubessy Cost effectiveness and resource allocation 1, 1-10, 2003 | 421 | 2003 |
| An update of the global burden of pertussis in children younger than 5 years: a modelling study KHT Yeung, P Duclos, EAS Nelson, RCW Hutubessy The Lancet Infectious Diseases 17 (9), 974-980, 2017 | 387 | 2017 |
| Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study M Jit, M Brisson, A Portnoy, R Hutubessy The Lancet Global health 2 (7), e406-e414, 2014 | 287 | 2014 |
| Cost effectiveness analysis of strategies for child health in developing countries TTT Edejer, M Aikins, R Black, L Wolfson, R Hutubessy, DB Evans Bmj 331 (7526), 1177, 2005 | 241 | 2005 |
| Health economics of dengue: a systematic literature review and expert panel's assessment ME Beatty, P Beutels, MI Meltzer, DS Shepard, J Hombach, R Hutubessy, ... The American journal of tropical medicine and hygiene 84 (3), 473, 2011 | 230 | 2011 |
| Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015 LJ Wolfson, F Gasse, SP Lee-Martin, P Lydon, A Magan, A Tibouti, ... Bulletin of the World Health organization 86, 27-39, 2008 | 224 | 2008 |
| WHO Guide for standardisation of economic evaluations of immunization programmes DG Walker, R Hutubessy, P Beutels Vaccine 28 (11), 2356-2359, 2010 | 194 | 2010 |
| World Health Organization call for action to eliminate cervical cancer globally M GÜLTEKİN, P Ramirez, N Broutet, R Hutubessy International Journal of Gynecological Cancer 30 (4), 2020 | 151 | 2020 |
| Indirect costs of back pain in the Netherlands: a comparison of the human capital method with the friction cost method RCW Hutubessy, MW van Tulder, H Vondeling, LM Bouter Pain 80 (1-2), 201-207, 1999 | 147 | 1999 |
| Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries R Deogaonkar, R Hutubessy, I Van Der Putten, S Evers, M Jit BMC public health 12, 1-9, 2012 | 139 | 2012 |
| Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review M Fesenfeld, R Hutubessy, M Jit Vaccine 31 (37), 3786-3804, 2013 | 138 | 2013 |
| The broader economic impact of vaccination: reviewing and appraising the strength of evidence M Jit, R Hutubessy, ME Png, N Sundaram, J Audimulam, S Salim, ... BMC medicine 13, 1-9, 2015 | 133 | 2015 |
| A systematic review of the social and economic burden of influenza in low-and middle-income countries N de Francisco, M Donadel, M Jit, R Hutubessy Vaccine 33 (48), 6537-6544, 2015 | 133 | 2015 |
| Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study AM Khatib, M Ali, L Von Seidlein, DR Kim, R Hashim, R Reyburn, B Ley, ... The Lancet infectious diseases 12 (11), 837-844, 2012 | 131 | 2012 |
